SCHEMBL4796015

SCHEMBL4796015

Cn1cnc(-c2ccc(NC(=O)Nc3ccccc3)cc2)c1-c1cc2c(N)ncnc2s1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 14/20 0.86
KDR P35968 14/20 0.74
FLT1 P17948 5/20 0.74
KIT P10721 7/20 0.51
FLT4 P35916 3/20 0.48
AURKA O14965 2/20 0.48
PLK4 O00444 2/20 0.48
DYRK3 O43781 2/20 0.48
MAP4K4 O95819 2/20 0.48
LCK P06239 2/20 0.48
FES P07332 2/20 0.48
LYN P07948 2/20 0.48
MET P08581 2/20 0.48
FER P16591 2/20 0.48
MARK3 P27448 2/20 0.48
AXL P30530 2/20 0.48
SYK P43405 2/20 0.48
CLK2 P49760 2/20 0.48
BLK P51451 2/20 0.48
IRAK1 P51617 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4796059 0.93 TEK (1.00) TEKKDRFLT1KITFLT4
SCHEMBL4800669 0.91 TEK (0.72) TEKKDRFLT1KITFLT4
SCHEMBL4802939 0.86 TEK (1.00) TEKKDRFLT1
SCHEMBL4802186 0.85 TEK (0.86) TEKKDRFLT1KITFLT4
SCHEMBL4471994 0.85 TEK (0.85) TEKKDRFLT1KITFLT4
SCHEMBL4480247 0.85 TEK (0.85) TEKKDRFLT1KITFLT4
SCHEMBL4484707 0.84 TEK (0.83) TEKKDRFLT1KITAURKA
SCHEMBL4467818 0.84 TEK (0.83) TEKKDRFLT1KITFLT4
SCHEMBL4801489 0.84 TEK (0.83) TEKKDRFLT1LIMK1RET
SCHEMBL4801912 0.84 TEK (0.85) TEKKDRFLT1KITFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537112-B1 CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY ASTRAZENECA AB (SE) 2006-04-19 EP claimed
US-20050256140-A1 Condensed pyridines and pyrimidines with tie2 (tek) activity ASTRAZENECA AB (SE) 2005-11-17 US claimed
US-7427616-B2 Condensed pyridines and pyrimidines with tie2 (TEK) activity ASTRAZENECA AB (SE) 2008-09-23 US disclosed
EP-1537112-B1 CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY ASTRAZENECA AB (SE) 2006-04-19 EP disclosed
US-20050256140-A1 Condensed pyridines and pyrimidines with tie2 (tek) activity ASTRAZENECA AB (SE) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256140-A1 Condensed pyridines and pyrimidines with tie2 (tek) activity TIE1, TEK, KDR TEK 2/4885KDR 3/4885FLT1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.